Breaking News Instant updates and real-time market news.

LYFT

Lyft

$0.00 /

+ (+0.00%)

20:00
03/19/19
03/19
20:00
03/19/19
20:00

Lyft initiated with a Buy at DA Davidson

DA Davidson analyst Tom White initiated Lyft with a Buy rating and a price target of $75 ahead of the company's IPO filing next week with a target price range of $62 to $68 per share. The analyst is positive on Lyft's "impressive U.S. market share gains, momentum, and continued growth of the broader Ridesharing market". White adds that the company's enterprise value to sales multiple appears to be "reasonable", even though he sees some uncertainty around Lyft's long-term margin ramp and autonomous driving technology positioning.

  • 19

    Mar

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

LYFT Lyft
$0.00 /

+ (+0.00%)

02/26/19 Nomura Instinet
Lyft may be making 'massive' migration away from MongoDB, says Nomura Instinet

TODAY'S FREE FLY STORIES

Hot Stocks
Menlo Therapeutics Inc trading resumes  08:00
02/26/20
02/26
08:00
02/26/20
08:00
MNLO

Menlo Therapeutics

$4.45 /

-0.53 (-10.64%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Bank of America put buyer realizes 123% same-day gains » 08:00
02/26/20
02/26
08:00
02/26/20
08:00
BAC

Bank of America

$31.10 /

-1.63 (-4.98%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Menlo Therapeutics announces results from Phase 2 trial for serlopitant » 08:00
02/26/20
02/26
08:00
02/26/20
08:00
MNLO

Menlo Therapeutics

$4.45 /

-0.53 (-10.64%)

Menlo Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
American Water management to meet with Guggenheim » 07:59
02/26/20
02/26
07:59
02/26/20
07:59
AWK

American Water

$133.08 /

-3.46 (-2.53%)

Meeting to be held in the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
SmileDirectClub downgraded to Hold from Buy at Jefferies » 07:58
02/26/20
02/26
07:58
02/26/20
07:58
SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

Jefferies analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Translate Bio receives Fast Track designation for MRT5005 » 07:58
02/26/20
02/26
07:58
02/26/20
07:58
TBIO

Translate Bio

$7.29 /

-0.03 (-0.41%)

Translate Bio announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lowe's comps light but margins better, says Baird » 07:58
02/26/20
02/26
07:58
02/26/20
07:58
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
InflaRx announces initial data from Phase IIa open label study with IFX-1 » 07:57
02/26/20
02/26
07:57
02/26/20
07:57
IFRX

InflaRx

$4.15 /

-0.1 (-2.35%)

InflaRx announces initial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Kratos Defense upgraded to Buy from Hold at Jefferies » 07:56
02/26/20
02/26
07:56
02/26/20
07:56
KTOS

Kratos Defense

$15.00 /

-4.3 (-22.28%)

Jefferies analyst Sheila…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Oramed trading halted, news pending  07:55
02/26/20
02/26
07:55
02/26/20
07:55
ORMP

Oramed

$4.86 /

-0.14 (-2.80%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WeedMD's Starseed signs Insulators Local 95 Fund to medicinal cannabis program » 07:55
02/26/20
02/26
07:55
02/26/20
07:55
WDDMF

WeedMD

$0.00 /

+ (+0.00%)

WeedMD announcef that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Salesforce reported strong end to the year, says JPMorgan » 07:54
02/26/20
02/26
07:54
02/26/20
07:54
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Guardion Health Sciences selected to develop immuno-supportive formula » 07:53
02/26/20
02/26
07:53
02/26/20
07:53
GHSI

Guardion Health Sciences

$0.29 /

-0.003 (-1.01%)

Guardion Health Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Liberty Broadband to host conference call » 07:53
02/26/20
02/26
07:53
02/26/20
07:53
LBRDK

Liberty Broadband

$133.37 /

-2.63 (-1.93%)

, LBRDA

Liberty Broadband

$134.76 /

+0.16 (+0.12%)

President & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Physicians Realty Trust reports Q4 normalized FFO 27c, consensus 27c » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
DOC

Physicians Realty Trust

$20.30 /

-0.36 (-1.74%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Unisys selected by European Fisheries Control Agency for IT services » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
UIS

Unisys

$15.88 /

-0.405 (-2.49%)

Unisys is partnering with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta plans to initiate IND-enabling studies for M267 in 2020 » 07:52
02/26/20
02/26
07:52
02/26/20
07:52
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

Momenta's SIFbody…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta says CSL plans to introduce M230 Phase 1 program this year » 07:51
02/26/20
02/26
07:51
02/26/20
07:51
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

M230: a recombinant Fc…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Disney weakness on CEO change a buying opportunity says JPMorgan » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
DIS

Disney

$128.24 /

-4.79 (-3.60%)

The timing of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects to report top-line data from Vivacity-MG study in 3Q20 » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

Nipocalimab: a fully…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Morgan Stanley staying cautious on cruise lines, cuts EPS estimates and targets » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
CCL

Carnival

$35.83 /

-1.95 (-5.16%)

, CUK

Carnival plc

$33.79 /

-1.91 (-5.35%)

, RCL

Royal Caribbean

$89.50 /

-7.03 (-7.28%)

, NCLH

Norwegian Cruise Line

$39.30 /

-3.32 (-7.79%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Freshpet price target raised to $70 from $45 at SunTrust » 07:50
02/26/20
02/26
07:50
02/26/20
07:50
FRPT

Freshpet

$74.53 /

+0.85 (+1.15%)

SunTrust analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27
    Feb
Recommendations
Jazz Pharmaceuticals lowered his price target to $165 from $200 at Cowen » 07:49
02/26/20
02/26
07:49
02/26/20
07:49
JAZZ

Jazz Pharmaceuticals

$127.50 /

-3.31 (-2.53%)

Cowen analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects to launch Phase 2 study of M254 in 4Q20 » 07:49
02/26/20
02/26
07:49
02/26/20
07:49
MNTA

Momenta

$30.79 /

-1.09 (-3.42%)

M254: a hypersialylated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Paramount Gold Nevada expects to complete modified CPA in 2Q20 » 07:47
02/26/20
02/26
07:47
02/26/20
07:47
PZG

Paramount Gold Nevada

$0.82 /

-0.1103 (-11.86%)

The Oregon Department of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.